ArticleThe journal of allergy and clinical immunology. Global2025

Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions.

Ian D Pavord et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.